Sildenafil citrate therapy in 22 dogs with pulmonary hypertension

Journal of Veterinary Internal Medicine

Volumn 21, Issue 6, 2007, Pages 1258-1264

  Kellum, Heidi B ^a,b   Stepien, Rebecca L ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Veterinary Medical Teaching Hospital   (United States)

Author keywords

Echocardiographic; Heart disease; Pulmonary disease; Systolic time intervals

Indexed keywords

PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SILDENAFIL; SULFONE; VASODILATOR AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; FEMALE; MALE; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY;

ANIMALS; DOGS; FEMALE; HYPERTENSION, PULMONARY; MALE; PIPERAZINES; PURINES; RETROSPECTIVE STUDIES; SULFONES; VASODILATOR AGENTS;

ANIMALIA; CANIS FAMILIARIS;

EID: 37349061721     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/07-006.1     Document Type: Article

References (26)

1. Fleming E, Ettinger S. Pulmonary hypertension. Compend Contin Educ Pract Vet 2006;28:720-730.
2. Johnson L, Boon J, Orton EC. Clinical characteristics of 53 dogs with Doppler-derived evidence of pulmonary hypertension: 1992-1996. J Vet Intern Med 1999;13:440-447.
3. Bach JF, Rozanski EA, MacGregor J, et al. Retrospective evaluation of sildenafil citrate as a therapy for pulmonary hypertension in dogs. J Vet Intern Med 2006;20:1132-1135.
4. Schober KE, Baade H. Doppler echocardiographic prediction of pulmonary hypertension in West Highland White Terriers with chronic pulmonary disease. J Vet Intern Med 2006;20:912-920.
5. Pyle RL, Abbott J, MacLean H. Pulmonary hypertension and cardiovascular sequelae in 54 dogs. Int J Appl Res Vet Med 2004;2:99.
6. Johnson LR, Hamlin RL. Recognition and treatment of pulmonary hypertension. In: Bonagura K, ed. Current Veterinary Therapy, XII ed. Philadelphia, PA: WB Saunders; 1995:887-891.
7. Hirano Y, Kitagawa H, Sasaki Y. Relationship between pulmonary arterial pressure and pulmonary thromboembolism associated with dead worms in canine heartworm disease. J Vet Med Sci 1992;54:897-904.
8. Serres FJ, Chetboul V, Tissier R, et al. Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001-2005). J Am Vet Med Assoc 2006;229:1772-1778.
9. Zabka TS, Campbell FE, Wilson DW. Pulmonary arteriopathy and idiopathic pulmonary arterial hypertension in six dogs. Vet Pathol 2006;43:510-522.
10. Glaus TM, Soldati G, Maurer R, Ehrensperger F. Clinical and pathological characterisation of primary pulmonary hypertension in a dog. Vet Rec 2004;154:786-789.
11. Glaus TM, Hassig M, Baumgartner C, Reusch CE. Pulmonary hypertension induced in dogs by hypoxia at different high-altitude levels. Vet Res Commun 2003;27:661-670.
12. Corcoran BM, Cobb M, Martin MW, et al. Chronic pulmonary disease in West Highland White Terriers. Vet Rec 1999; 144:611-616.
13. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425-1436.
14. Thomas WP, Gaber CE, Jacobs GJ, et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine. J Vet Intern Med 1993;7:247-252.
15. Martin-Duran R, Larman M, Trugeda A, et al. Comparison of Doppler-determined elevated pulmonary arterial pressure with pressure measured at cardiac catheterization. Am J Cardiol 1986;57:859-863.
16. Uehara Y. An attempt to estimate the pulmonary artery pressure in dogs by means of pulsed Doppler echocardiography. J Vet Med Sci 1993;55:307-312.
17. Johnson L. Diagnosis of pulmonary hypertension. Clin Tech Small Anim Pract 1999;14:231-236.
18. Haworth SG. Pulmonary hypertension. In: Moller JH, Hoffman JI, eds. Pediatric Cardiovascular Medicine. Philadelphia, PA: Churchill Livingstone; 2000:709-713.
19. Michelakis ED, Tymchak W, Noga M, et al. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 2003;108:2066-2069.
20. Galie N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:2148-2157.
21. Humpl T, Reyes JT, Holtby H, Stephens D, et al. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: Twelve-month clinical trial of a single-drug, open-label, pilot study. Circulation 2005;111:3274-3280.
22. Ghofrani HA, Wiedemann R, Rose F, et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: A randomised controlled trial. Lancet 2002;360:895-900.
23. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984;70:657-662.
24. Jardin F, Dubourg O, Bourdarias JP. Echocardiographic pattern of acute cor pulmonale. Chest 1997;111:209-217.
25. Kosturakis D, Goldberg SJ, Allen HD, Loeber C. Doppler echocardiographic prediction of pulmonary arterial hypertension in congenital heart disease. Am J Cardiol 1984;53:1110-1115.
26. Grover RF, Johnson RL Jr, McCullough RG, et al. Pulmonary hypertension and pulmonary vascular reactivity in beagles at high altitude. J Appl Physiol 1988;65:2632-2640.